Document Detail


Value and Level of Galectin-3 in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
MedLine Citation:
PMID:  23037954     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aim: This study investigated the impact of the circulating galectin-3 level on the 30-day prognostic outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Methods: From May 2009 to March 2011, blood samples for assessment of the circulating galectin-3 level were collected from 196 consecutive STEMI patients treated by primary PCI and from 30 healthy volunteers.Results: The galectin-3 level was determined using ELISA. Our results demonstrated that the circulating level of galectin-3 was significantly higher in STEMI patients than in healthy control subjects (p<0.001). As compared with patients with galectin-3 <7.67 ng/mL, patients with galectin-3 ≥7.67 ng/mL were significantly older, had significantly lower left ventricular ejection fraction and significantly higher frequency of elevated white blood cell count, advanced Killip score (defined as ≥ score 3), congestive heart failure (defined as ≥ New York Heart Association Functional Class III), respiratory failure, unstable hemodynamics requiring a mechanical ventilator and intra-aortic balloon pump support, multiple vessel diseases and 30-day mortality (all p<0.04). Furthermore, multivariate analysis showed that elevated circulating level of galectin-3 was the strongest independent predictor of the combined 30-day major adverse clinical outcome (MACO) (defined as advanced CHF or 30-day mortality) (p<0.0001).Conclusion: A high circulating galectin-3 level may serve as a useful biomarker for predicting 30-day MACO in patients with STEMI undergoing primary PCI.
Authors:
Tzu-Hsien Tsai; Pei-Hsun Sung; Li-Teh Chang; Cheuk-Kwan Sun; Kuo-Ho Yeh; Sheng-Ying Chung; Sarah Chua; Yung-Lung Chen; Chiung-Jen Wu; Hsuen-Wen Chang; Sheung-Fat Ko; Hon-Kan Yip
Related Documents :
19830644 - Flow-targeted inversion-prepared b-tfe coronary mr angiography: initial results in pati...
25110754 - High association between human circulating microrna-497 and acute myocardial infarction.
25125324 - Short- and long-term prognosis of previous and new-onset atrial fibrillation in st-segm...
19185934 - Clinical management and short-term cost - 64-slice mdct vs. myocardial perfusion scinti...
21784744 - Dynamic ventricular overdrive stimulation in atrial fibrillation: effects on ventricula...
9845564 - Intraoperative laser doppler flowmetry: a predictor of ischemic injury in acute mesente...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-03
Journal Detail:
Title:  Journal of atherosclerosis and thrombosis     Volume:  -     ISSN:  1880-3873     ISO Abbreviation:  J. Atheroscler. Thromb.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506298     Medline TA:  J Atheroscler Thromb     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptos...
Next Document:  Asymmetric catalysis based on tropos ligands.